首页> 外文期刊>Iranian red crescent medical journal >Factors Associated With Serum Albumin in Diabetes Mellitus Type 2 With Microalbuminuria Using Non-Normal Mixed Models: A Prospective Cohort Study
【24h】

Factors Associated With Serum Albumin in Diabetes Mellitus Type 2 With Microalbuminuria Using Non-Normal Mixed Models: A Prospective Cohort Study

机译:非正常混合模型与2型糖尿病合并微量白蛋白尿患者血清白蛋白相关因素的前瞻性队列研究

获取原文
           

摘要

The globally increasing epidemic of diabetes will lead to serious problems including diabetic nephropathy and kidney diseases in near future. The first clinical diagnosable stage in a diabetic kidney disease is microalbuminuria (urinary albumin excretion of 30 - 300 g/24 hours). Objectives: This prospective cohort study investigated the risk factors of microalbuminuria in patients with type 2 diabetes who had been registered in endocrine and metabolism research center in Isfahan city, Iran. Patients and Methods: This prospective cohort study was performed on 90 diabetic type 2 patients with microalbuminuria, who were selected according to the consecutive sample selection method during 6 years. Data were collected through regular and systematic measurements of serum albumin as the response variable and body mass index, systolic and diastolic blood pressure, the duration of diabetes, glycosylated hemoglobin (HbA1c), total cholesterol, triglyceride (TG), fasting blood sugar (FBS), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) as the related factors. Non-normal mixed models were used to investigate the impact of effective factors on the amount of excreted serum albumin. Results: According to the deviance information criterion (DIC = 56.2), the non-normal mixed effects model with the skewed t distribution had a best fit and indicated that HbA1c, HDL and total cholesterol had a significant effect on the amount of albumin in urine (P < 0.05). Conclusions: Using nonnormal mixed models may lead to the best results as compared to common normality assumption.
机译:全球范围内日益流行的糖尿病流行将在不久的将来导致严重的问题,包括糖尿病性肾病和肾脏疾病。糖尿病性肾脏疾病的第一个临床可诊断阶段是微量白蛋白尿(尿白蛋白排泄30-300 g / 24小时)。目的:这项前瞻性队列研究调查了在伊朗伊斯法罕市内分泌和代谢研究中心注册的2型糖尿病患者微量白蛋白尿的危险因素。患者与方法:这项前瞻性队列研究是针对90名2型糖尿病合并微量白蛋白尿的患者进行的,这些患者是根据6年中的连续样本选择方法选择的。通过定期和系统地测量血清白蛋白作为反应变量和体重指数,收缩压和舒张压,糖尿病病程,糖化血红蛋白(HbA1c),总胆固醇,甘油三酸酯(TG),空腹血糖(FBS)收集数据),低密度脂蛋白(LDL)和高密度脂蛋白(HDL)作为相关因素。使用非正常混合模型研究有效因素对分泌的血清白蛋白量的影响。结果:根据偏差信息标准(DIC = 56.2),具有偏t分布的非正态混合效应模型最适合,表明HbA1c,HDL和总胆固醇对尿液中白蛋白含量有显着影响(P <0.05)。结论:与普通正态性假设相比,使用非正态混合模型可能会导致最佳结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号